Intercept Pharmaceuticals's President & CEO just disposed of 2,034 shares

Jerome Benedict Durso, Intercept Pharmaceuticals's President & CEO and a director of the company, recently disposed of 2,034 shares of the company. The disposals took place at $24.70 per share, on dates ranging from December 31 to January 01, 2021. Durso still owns 36,750 shares of the company. Durso operates out of New York, NY. Some additional info was provided as follows:

Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Intercept Pharmaceuticals makes a similar move, sign up!

Other recent filings from the company include the following:

Intercept Pharmaceuticals's Chief Qual. Officer & SVP Ops. just disposed of 2,455 shares - Jan. 13, 2022
Departure of Directors or Certain - Jan. 10, 2022
Statement of changes in beneficial ownership of securities - Jan. 4, 2022
SVP of Intercept Pharmaceuticals just disposed of 2,455 shares - Jan. 4, 2022
SVP of Intercept Pharmaceuticals just disposed of 542 shares - Jan. 4, 2022

Auto Refresh